HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Clinical trial NCT05512598 · COMPLETED

Trial details

NCT number: NCT05512598
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Generalized Pustular Psoriasis

Start date: 2022-11-06
Primary completion: 2023-11-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.